Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus

Abstract

Objective

Draw upon research into the serum concentration, mRNA expression, and DNA methylation of TNF-like weak inducer of apoptosis (TWEAK) in the peripheral blood of systemic lupus erythematosus patients and healthy controls in an attempt to investigate the epigenetics associated with TWEAK in the pathogenesis of systemic lupus erythematosus (SLE).

Methods

A total of 178 SLE patients (SLE group) and 131 sex-age matched healthy controls (HC group) were recruited. Enzyme-linked immunosorbent assays (ELISA) was used to detect serum protein concentration of TWEAK. TWEAK mRNA expression was analyzed by Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Methylation levels of the promotor of TWEAK were measured using quantitative DNA methylation analysis on the MassARRAY spectrometry.

Results

Serum TWEAK concentrations were not statistically significant in SLE patients and HCs. Nevertheless, serum TWEAK concentrations were significantly lower in patients with renal involvement when compared to those without it. Serum TWEAK concentrations were reduced in clinically active patients (SLEDAI ≥ 10) compared with clinically stable patients (SLEDAI < 10). It was also significantly associated with SLEDAI. Compared with the HC group, the TWEAK mRNA expression in the SLE group was significantly lower. The global DNA methylation levels of TWEAK in the SLE group were observed to be significantly higher than the HC group. SLE patients with renal involvement, and the clinically active patients had higher TWEAK global methylation as well as exhibited variation in certain CpG island methylation. Furthermore, TWEAK methylation negatively correlated with TWEAK mRNA expression.

Conclusion

This study suggests that TWEAK DNA methylation is a valuable as a focus for epigenetic studies because of it potentially influencing TWEAK gene expression in SLE patients. Aberrant DNA methylation of TWEAK may be involved in the initiation and development of SLE.

Keywords

Systemic lupus erythematosus TNF-like weak inducer of apoptosis DNA methylation mRNA expression serum concentration

Get full access to this article

View all access options for this article.

References

Javierre

Fernandez

Richter

, et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 2010; 20: 170–179. DOI: 10.1101/gr.100289.109

Hewagama

Gorelik

Patel

, et al. Overexpression of X-linked genes in T cells from women with lupus. J Autoimmun 2013; 41: 60–71. DOI: 10.1016/j.jaut.2012.12.006

Jeffries

Dozmorov

Tang

, et al. Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus. Epigenetics 2011; 6: 593–601. DOI: 10.4161/epi.6.5.15374

Zhao

Liu

Luo

, et al. DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. J Autoimmun 2014; 54: 127–136. DOI: 10.1016/j.jaut.2014.07.002

Garaud

Le Dantec

Jousse-Joulin

, et al. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J Immunol 2009; 182: 5623–5632. DOI: 10.4049/jimmunol.0802412

Basu

Liu

, et al. Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells. J Immunol 2009; 183: 3481–3487. DOI: 10.4049/jimmunol.0900034

Sunahori

Nagpal

Hedrich

, et al. The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/phosphorylated ERK/DNMT1 protein pathway in T-cells from controls and systemic lupus erythematosus patients. J Biol Chem 2013; 288: 21936–21944. DOI: 10.1074/jbc.M113.467266

Liu

Lin

Yen

, et al. Demethylation within the proximal promoter region of human estrogen receptor alpha gene correlates with its enhanced expression: implications for female bias in lupus. Mol Immunol 2014; 61: 28–37. DOI: 10.1016/j.molimm.2014.05.002

Vordenbäumen

Sokolowski

Rosenbaum

, et al. Methyl donor micronutrients, CD40-ligand methylation and disease activity in systemic lupus erythematosus: a cross-sectional association study. Lupus 2021; 30(11): 1773–1780. DOI: 10.1177/09612033211034559

10.

Zhang

Cheng

, et al. Hypomethylation of the HTR1A promoter region and high expression of HTR1A in the peripheral blood lymphocytes of patients with systemic lupus erythematosus. Lupus 2011; 20: 678–689. DOI: 10.1177/0961203310394892

11.

Zhang

Zhou

, et al. Difference of IFI44L methylation and serum IFN-a1 level among patients with discoid and systemic lupus erythematosus and healthy individuals. J Transl Autoimmun 2021; 4: 100092. DOI: 10.1016/j.jtauto.2021.100092

12.

Nakayama

Ishidoh

Kojima

, et al. Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death. J Immunol 2003; 170: 341–348. DOI: 10.4049/jimmunol.170.1.341

13.

Lynch

Wang

Lund

, et al. TWEAK induces angiogenesis and proliferation of endothelial cells. J Biol Chem 1999; 274: 8455–8459. DOI: 10.1074/jbc.274.13.8455

14.

Wiley

Cassiano

Lofton

, et al. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 2001; 15: 837–846. DOI: 10.1016/s1074-7613(01)00232-1

15.

Sun

Teng

, et al. Involvement of TWEAK and the NF-kappaB signaling pathway in lupus nephritis. Exp Ther Med 2018; 15: 2611–2619. DOI: 10.3892/etm.2018.5711

16.

Wen

Xia

Stock

, et al. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway. J Autoimmun 2013; 43: 44–54. DOI: 10.1016/j.jaut.2013.03.002

17.

Wen

Doerner

Weidenheim

, et al. TNF-like weak inducer of apoptosis promotes blood–brain barrier disruption and increases neuronal cell death in MRL/lpr mice. J Autoimmun 2015; 60: 40–50. DOI: 10.1016/j.jaut.2015.03.005

18.

Hochberg

. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725. DOI: 10.1002/art.1780400928

19.

Bombardier

CGD

Urowitz

Caron

, et al. Derivation of the SLEDAI A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630–640.

20.

Mirioglu

Cinar

Yazici

, et al. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus. Lupus 2020; 29(4): 379–388. DOI: 10.1177/0961203320904997

21.

Choe

Kim

. Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus. Inflamm Res 2016; 65: 479–488. DOI: 10.1007/s00011-016-0930-5

22.

Chicheportiche

Fossati-Jimack

Moll

, et al. Down-regulated expression of TWEAK mRNA in acute and chronic inflammatory pathologies. Biochem biophysical Res Commun 2000; 279: 162–165. DOI: 10.1006/bbrc.2000.3913

23.

Wang

Chen

Pan

, et al. Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus. Clin Rheumatol 2012; 31: 335–339. DOI: 10.1007/s10067-011-1865-4

24.

Liao

, et al. Epigenetics as biomarkers in autoimmune diseases. Clin Immunol 2018; 196: 34–39. DOI: 10.1016/j.clim.2018.03.011

25.

Liang

Zhu

Qin

, et al. A correlation study on the effects of DNMT1 on methylation levels in CD4(+) T cells of SLE patients. Int J Clin Exp Med 2015; 8: 19701–19708.

26.

Fang

Lin

Liu

, et al. Methylation and gene expression of histone deacetylases 6 in systemic lupus erythematosus. Int J Rheum Dis 2016; 19: 968–973. DOI: 10.1111/1756-185x.12783

27.

Funes

Fernandez-Fierro

Rebolledo-Zelada

, et al. Contribution of dysregulated DNA methylation to autoimmunity. Int J Mol Sci 2021: 22. DOI: 10.3390/ijms222111892

28.

Ballestar

. Epigenetic alterations in autoimmune rheumatic diseases. Nat Rev Rheumatol 2011; 7: 263–271. DOI: 10.1038/nrrheum.2011.16

29.

Bernstein

Meissner

Lander

. The mammalian epigenome. Cell 2007; 128: 669–681. DOI: 10.1016/j.cell.2007.01.033

30.

Chen

Fan

Shou

, et al. Hypermethylation of glucocorticoid receptor gene promoter results in glucocorticoid receptor gene low expression in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Rheumatol Int 2015; 35: 1335–1342. DOI: 10.1007/s00296-015-3266-5